Eastman Chemical (EMN) reported $2.29 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 0.9%. EPS of $1.91 for the same period compares to $1.61 a year ago.
The reported revenue represents a surprise of -0.81% over the Zacks Consensus Estimate of $2.31 billion. With the consensus EPS estimate being $1.89, the EPS surprise was +1.06%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Eastman Chemical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Sales- Chemical Intermediates: $545 million versus the five-analyst average estimate of $526.41 million. The reported number represents a year-over-year change of +4.2%.
- Net Sales- Fibers: $288 million compared to the $323.18 million average estimate based on five analysts. The reported number represents a change of -13% year over year.
- Net Sales- Advanced Materials: $719 million compared to the $764.65 million average estimate based on five analysts. The reported number represents a change of -3.9% year over year.
- Net Sales- Additives & Functional Products: $733 million versus $706.46 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +4.1% change.
- Net Sales- Other: $5 million compared to the $4.50 million average estimate based on two analysts. The reported number represents a change of +25% year over year.
- Adjusted EBIT- Additives & Functional Products: $141 million versus $127.78 million estimated by four analysts on average.
- Adjusted EBIT- Advanced Materials: $116 million compared to the $114.17 million average estimate based on four analysts.
- Adjusted EBIT- Chemical Intermediates: $19 million versus the four-analyst average estimate of $22.78 million.
- Adjusted EBIT- Other: -$53 million compared to the -$53.70 million average estimate based on four analysts.
- Adjusted EBIT- Fibers: $88 million compared to the $98.13 million average estimate based on four analysts.
View all Key Company Metrics for Eastman Chemical here>>>
Shares of Eastman Chemical have returned -12% over the past month versus the Zacks S&P 500 composite's -5.1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Eastman Chemical Company (EMN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
